“perceptive-advisors” Archives

in
Entry Author Date Location
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia 08/12/20 San Francisco
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Thrive Adds $257M, Plans Pivotal Trial of Early Cancer Detection Test 07/29/20 National
AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis 06/24/20 National
Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx 06/22/20 San Francisco
C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic 06/16/20 Boston
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain” 06/09/20 Boston
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses 05/01/20 Boston
Dynacure Adds $55M As RNA-Targeted Muscle Disorder Drug Enters Clinic 04/03/20 Boston
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies 12/18/19 Boulder/Denver
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs 11/13/19 San Diego
With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer 10/28/19 New York
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
Freenome Snags $160M to Boost Blood Test for Early Cancer Detection 07/24/19 San Francisco
Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets 07/18/19 San Francisco
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome 06/26/19 Boulder/Denver
Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round 04/22/19 San Diego
BridgeBio Pharma Hauls in $299M for Genetic Disease Drugs R&D 01/23/19 San Francisco
Black Diamond Gets $85M for Cancer Drugs R&D and New Cambridge HQ 01/10/19 Boston
Relay Raises $400M to Kick Protein Motion Drug R&D into High Gear 12/20/18 Boston
With $90M Round, Stoke Eyes a “Spinraza For Epilepsy” And a 2019 IPO 10/23/18 Boston
Kodiak Sciences Files for IPO to Fund Global AMD Eye-Drug Studies 09/10/18 San Francisco
On Cusp of Gene Therapy Clinical Trial, 4D Molecular Reels In $90M 09/05/18 San Francisco
Renovia Raises $42M to Back Digital Treatment for Incontinence 08/21/18 Boston
Alector Snags $133M to Activate Immune Cells Against Neurodegeneration 07/25/18 San Francisco
Page 1 of 2 next page »